IXC 1.41% 7.0¢ invex therapeutics ltd

Ann: Trading Halt, page-23

  1. 2,379 Posts.
    lightbulb Created with Sketch. 717
    the answer to your first paragraph is simply that there would not be the interest from 708 holders without the anticipated upside from positive results still to be announced (note I didn't say "certain" upside). If in the scenario you offered the price ran following results and then the raising was offered at a discount, the price would simply retrace to the raising price as all news/upside to that time had been priced in. They certainly wouldn't be getting my involvement at that point, nor any of the other 708 holders I know.

    Your second paragraph is baffling, assuming positive phase 2 results and over $20M in cash to facilitate phase three how could it be the worst possible outcome for retail holders?
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
-0.001(1.41%)
Mkt cap ! $5.260M
Open High Low Value Volume
7.0¢ 7.0¢ 7.0¢ $378 5.405K

Buyers (Bids)

No. Vol. Price($)
1 22915 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 22452 2
View Market Depth
Last trade - 10.04am 09/09/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.